Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Immunogenicity objectives 1.To demonstrate non-inferiority of MenACWY vaccine to that of MenC vaccine given to healthy toddlers, as measured by the percentage of subjects with serum bactericidal assay using human complement (hSBA) titers ≥8 against N. meningitidis serogroup C, at 28 days after the vaccination. Safety objectives: 1. To assess the safety and reactogenicity of MenACWY and MenC vaccines.
Critère d'inclusion
- To demonstrate non-inferiority of MenACWY vaccine to that of MenC vaccine
- given to healthy toddlers, as measured by the percentage of subjects with serum
- bactericidal assay using human complement (hSBA) titers ≥8 against N.
- meningitidis serogroup C, at 28 days after the vaccination